LATEST ONCOPRESCRIBE UPDATES
Bispecific Immune Checkpoint Inhibitor Improves Survival in Gastric and GEJ Cancer Regardless of PD-L1 Status
De-escalation of Treatment for HPV-Associated Oropharyngeal Cancer
Benefits of Neoadjuvant Chemoimmunotherapy in Early Stage Non Small Cell Lung Cancer
100 Percent Biochemical Recurrence Free Survival with Apalutamide plus ADT in High-Risk Prostate Cancer Following Radical Prostatectomy
Cardiovascular Adverse Events Associated with Bispecific T-cell Engager Therapy
Minimal Residual Disease Status Predicts Outcome in Patients with Previously Untreated Follicular Lymphoma
New ASCO Guideline Recommends Germline Testing in ALL Newly Diagnosed Breast Cancer Patients 65 Years or Younger
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C